CENTRALPHL Stock Overview
Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Central Pharmaceuticals Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ৳31.10 |
52 Week High | ৳35.60 |
52 Week Low | ৳10.00 |
Beta | 0.097 |
1 Month Change | 3.32% |
3 Month Change | 53.96% |
1 Year Change | 207.92% |
3 Year Change | 159.17% |
5 Year Change | 123.74% |
Change since IPO | 56.49% |
Recent News & Updates
Recent updates
Shareholder Returns
CENTRALPHL | BD Pharmaceuticals | BD Market | |
---|---|---|---|
7D | 8.7% | -2.1% | -2.1% |
1Y | 207.9% | -13.5% | -14.5% |
Return vs Industry: CENTRALPHL exceeded the BD Pharmaceuticals industry which returned -13.5% over the past year.
Return vs Market: CENTRALPHL exceeded the BD Market which returned -14.5% over the past year.
Price Volatility
CENTRALPHL volatility | |
---|---|
CENTRALPHL Average Weekly Movement | 13.0% |
Pharmaceuticals Industry Average Movement | 5.6% |
Market Average Movement | 5.7% |
10% most volatile stocks in BD Market | 9.1% |
10% least volatile stocks in BD Market | 3.3% |
Stable Share Price: CENTRALPHL's share price has been volatile over the past 3 months.
Volatility Over Time: CENTRALPHL's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1980 | 74 | Munsur Ahamed | https://www.centralphl.com |
Central Pharmaceuticals Ltd. manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh. It operates in Tablet, Capsule, Liquid, and Ointment segments. The company offers its products in various therapeutic areas, including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, musculoskeletal, dermatological, anti-diabetic, and oral rehydration salt.
Central Pharmaceuticals Ltd. Fundamentals Summary
CENTRALPHL fundamental statistics | |
---|---|
Market cap | ৳3.73b |
Earnings (TTM) | -৳45.54m |
Revenue (TTM) | ৳89.76m |
41.5x
P/S Ratio-81.8x
P/E RatioIs CENTRALPHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CENTRALPHL income statement (TTM) | |
---|---|
Revenue | ৳89.76m |
Cost of Revenue | ৳108.32m |
Gross Profit | -৳18.55m |
Other Expenses | ৳26.98m |
Earnings | -৳45.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.38 |
Gross Margin | -20.67% |
Net Profit Margin | -50.73% |
Debt/Equity Ratio | -3.2% |
How did CENTRALPHL perform over the long term?
See historical performance and comparison